In this video, INSIDER explores, in part, the industry's reaction to FDA's tentative determination that vinpocetine should not remain on the market as a dietary supplement.

December 7, 2016

Vinpocetine has been on the market as a dietary supplement for approximately the last 20 years. That could soon change thanks to a Federal Register notice that was published in September by FDA.

In this video, INSIDER explores:

-- FDA’s reasoning for its tentative conclusions that vinpocetine shouldn’t remain on the market as a dietary supplement;

-- reaction from trade associations to the Federal Register notice; and

-- a silver lining to the development for industry.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like